Baxion
Screening
Tags
Alerts
Theme
Alto Neuroscience, Inc.
ANRO
·
NYSE
·
$21.06
Share Price as of 11/2
·
$739M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/12/26
10-Q
Q1 ended 03/31/26
05/13/26
10-K
FY 2025
03/16/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/13/25
Disclosures
Filter
8-K
Current report
08/27/26
8-K
Current report
08/12/26
8-K
Current report
07/14/26
8-K
Current report
07/13/26
8-K
Current report
05/28/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
07/14/26
S-3
Shelf registration
04/10/26
S-8
Registration of securities for employees
03/16/26
S-3
Shelf registration
11/28/25
S-8
Registration of securities for employees
03/20/25
Proxies
Filter
DEF 14A
Definitive proxy
03/26/26
DEFA14A
Additional proxy materials
03/26/26
DEFR14A
Definitive proxy (revised)
05/09/25
DEF 14A
Definitive proxy
04/01/25
DEFA14A
Additional proxy materials
04/01/25
Ownership
Filter
Form 4
Insider transaction
10/05/26
Form 4
Insider transaction
10/01/26
144
Proposed sale of securities
09/29/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
EFFECT
Request for effectiveness
04/20/26
CORRESP
Correspondence with the SEC
04/17/26
UPLOAD
Letter from the SEC
04/16/26
ARS
Annual report to shareholders
03/26/26
EFFECT
Request for effectiveness
12/10/25
Latest Filings
Filter
8-K
Current report
08/27/26
10-Q
Q2 ended 06/30/26
08/12/26
8-K
Current report
08/12/26
8-K
Current report
07/14/26
424B5
Prospectus supplement
07/14/26
Ownership
Filter
Form 4
Insider transaction
10/05/26
Form 4
Insider transaction
10/01/26
144
Proposed sale of securities
09/29/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26